Audax private equity announces agreement to sell corevitas to thermo fisher scientific

Boston & san francisco--(business wire)--audax private equity (“audax”), a leading alternative investment manager and capital partner for north american middle market companies, announced today it has entered into a definitive agreement to sell corevitas, llc (“corevitas”), a leading provider of real-world evidence for regulatory approved medical treatments and therapies, to thermo fisher scientific inc. (nyse: tmo) (“thermo fisher”). the transaction is expected to be completed by the end of 20.
TMO Ratings Summary
TMO Quant Ranking